deltatrials
Completed PHASE4 NCT00981435

Steroids After Laser Trabeculoplasty for Glaucoma

Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT

Sponsor: Bascom Palmer Eye Institute

Conditions Glaucoma
Interventions Artificial Tears Ketorolac Prednisolone 1%
Updated 9 times since 2017 Last updated: Jul 23, 2019 Started: Sep 30, 2009 Primary completion: Sep 30, 2015 Completion: Sep 30, 2015

This PHASE4 trial investigates Glaucoma and is currently completed. Bascom Palmer Eye Institute leads this study, which shows 9 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Jan 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Sep 2019 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jun 2018 — Sep 2019 [monthly]

    Completed PHASE4

  3. May 2017 — Jun 2018 [monthly]

    Completed PHASE4

  4. Jan 2017 — May 2017 [monthly]

    Completed PHASE4

    First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bascom Palmer Eye Institute
  • Stanford University
  • University of Pittsburgh Medical Center
Data source: Stanford University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Miami, United States
  • • Pittsburgh, United States